Abstract
Patients with human papillomavirus type 16 (HPV)-associated oropharyngeal
squamous cell carcinomas (OPSCC) display increased sensitivity to radiotherapy and
improved survival rates in comparison to HPV-negative forms of the disease. However
the cellular mechanisms responsible for this characteristic difference are unclear.
Here, we have investigated the contribution of DNA damage repair pathways to the
in vitro radiosensitivity of OPSCC cell lines. We demonstrate that two HPV-positive
OPSCC cells are indeed more radiosensitive than two HPV-negative OPSCC cells, which
correlates with reduced efficiency for the repair of ionising radiation (IR)-induced
DNA double strand breaks (DSB). Interestingly, we show that HPV-positive OPSCC
cells consequently have upregulated levels of the proteins XRCC1, DNA polymerase β,
PNKP and PARP-1 which are involved in base excision repair (BER) and single strand
break (SSB) repair. This translates to an increased capacity and efficiency for the
repair of DNA base damage and SSBs in these cells. In addition, we demonstrate
that HPV-positive but interestingly more so HPV-negative OPSCC display increased
radiosensitivity in combination with the PARP inhibitor olaparib. This suggests that
PARP inhibition in combination with radiotherapy may be an effective treatment
for both forms of OPSCC, particularly for HPV-negative OPSCC which is relatively
radioresistant.
squamous cell carcinomas (OPSCC) display increased sensitivity to radiotherapy and
improved survival rates in comparison to HPV-negative forms of the disease. However
the cellular mechanisms responsible for this characteristic difference are unclear.
Here, we have investigated the contribution of DNA damage repair pathways to the
in vitro radiosensitivity of OPSCC cell lines. We demonstrate that two HPV-positive
OPSCC cells are indeed more radiosensitive than two HPV-negative OPSCC cells, which
correlates with reduced efficiency for the repair of ionising radiation (IR)-induced
DNA double strand breaks (DSB). Interestingly, we show that HPV-positive OPSCC
cells consequently have upregulated levels of the proteins XRCC1, DNA polymerase β,
PNKP and PARP-1 which are involved in base excision repair (BER) and single strand
break (SSB) repair. This translates to an increased capacity and efficiency for the
repair of DNA base damage and SSBs in these cells. In addition, we demonstrate
that HPV-positive but interestingly more so HPV-negative OPSCC display increased
radiosensitivity in combination with the PARP inhibitor olaparib. This suggests that
PARP inhibition in combination with radiotherapy may be an effective treatment
for both forms of OPSCC, particularly for HPV-negative OPSCC which is relatively
radioresistant.
Original language | English |
---|---|
Pages (from-to) | 29963-29975 |
Journal | Oncotarget |
Volume | 8 |
Issue number | 18 |
Early online date | 16 Mar 2017 |
DOIs | |
Publication status | Published - 16 Mar 2017 |